RheumNow/LinkedIn
Jan 11, 2026, 09:58
Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
RheumNow shared a post on LinkedIn about a paper by Beatriz Grand et al. published in Lupus:
“100 women w/ severe preeclampsia (PE) compared to 40 pregnant controls. antiphospholipid antibodies (aPL) was significantly more prevalent in PE women (34% vs 10%) [OR = 4.63]. aPL positivity was also linked to both early and late severe PE [OR = 4-5, p = .008].”
Title: Exploring the association between preeclampsia and antiphospholipid antibodies. A prospective study
Authors: Beatriz Grand, Sebastián Udry, Andrea Avigliano, Mónica González Alcántara, José Omar Latino, Liliana Susana Voto
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 27, 2026, 13:45Alberto Sifuentes Giraldo: Innovative CAR–T Cell Therapy Promises SLE Remission and Fertility
-
Feb 27, 2026, 13:27Ovarian Reserve’s Impact on Miscarriage Risk – RBMO
-
Feb 27, 2026, 13:12ACOG’s Outstanding Editorial Team for Menopause – ACOG
-
Feb 27, 2026, 11:26Phase-Dependent Cytokine Dynamics of Endometrium – Fertility and Sterility
-
Feb 27, 2026, 08:51Pregnancy with Lupus Is No Longer a Distant Possibility – The Lupus Foundation of Australia
-
Feb 27, 2026, 08:43Celebrate Your Triumphs: Share Your Joyful Milestones – ASRM
-
Feb 27, 2026, 08:30Exploring Maternal Mental Health and Neonatal Risks in SSRI Study – AJOG MFM
-
Feb 27, 2026, 08:25Trust in Data, Trust in Science: Webinar on Research Integrity and Patient Safety – ESHRE
-
Feb 27, 2026, 08:13Have You Registered for Our Next Journal Webinar Yet? – RBMO